nodes	percent_of_prediction	percent_of_DWPC	metapath
Trabectedin—SRC—GAB1 signalosome—ERBB2—bile duct cancer	0.00277	0.00277	CbGpPWpGaD
Trabectedin—SRC—TSLP Signaling Pathway—IL6—bile duct cancer	0.00275	0.00275	CbGpPWpGaD
Trabectedin—SRC—AGE/RAGE pathway—EGFR—bile duct cancer	0.00272	0.00272	CbGpPWpGaD
Trabectedin—SRC—Rac1/Pak1/p38/MMP-2 pathway—EGFR—bile duct cancer	0.00269	0.00269	CbGpPWpGaD
Trabectedin—SRC—ErbB Signaling Pathway—TP53—bile duct cancer	0.00268	0.00268	CbGpPWpGaD
Trabectedin—CYP2C9—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.00265	0.00265	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.00262	0.00262	CbGpPWpGaD
Trabectedin—SRC—Oncostatin M Signaling Pathway—KRAS—bile duct cancer	0.0026	0.0026	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—HGF—bile duct cancer	0.00259	0.00259	CbGpPWpGaD
Trabectedin—SRC—ErbB Signaling Pathway—HRAS—bile duct cancer	0.00257	0.00257	CbGpPWpGaD
Trabectedin—SRC—Rac1/Pak1/p38/MMP-2 pathway—KRAS—bile duct cancer	0.00254	0.00254	CbGpPWpGaD
Trabectedin—SRC—EPH-Ephrin signaling—MMP9—bile duct cancer	0.00254	0.00254	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways in Glioblastoma—NRAS—bile duct cancer	0.00251	0.00251	CbGpPWpGaD
Trabectedin—SRC—NCAM signaling for neurite out-growth—KRAS—bile duct cancer	0.00251	0.00251	CbGpPWpGaD
Trabectedin—SRC—Kit receptor signaling pathway—HRAS—bile duct cancer	0.00239	0.00239	CbGpPWpGaD
Trabectedin—SRC—Oncostatin M Signaling Pathway—TP53—bile duct cancer	0.00231	0.00231	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—MET—bile duct cancer	0.00231	0.00231	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways in Glioblastoma—EGFR—bile duct cancer	0.00229	0.00229	CbGpPWpGaD
Trabectedin—SRC—Endothelins—HRAS—bile duct cancer	0.00227	0.00227	CbGpPWpGaD
Trabectedin—SRC—Rac1/Pak1/p38/MMP-2 pathway—TP53—bile duct cancer	0.00226	0.00226	CbGpPWpGaD
Trabectedin—SRC—LPA receptor mediated events—HRAS—bile duct cancer	0.00224	0.00224	CbGpPWpGaD
Trabectedin—SRC—Oncostatin M Signaling Pathway—HRAS—bile duct cancer	0.00221	0.00221	CbGpPWpGaD
Trabectedin—SRC—TSH signaling pathway—HRAS—bile duct cancer	0.00219	0.00219	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways in Glioblastoma—KRAS—bile duct cancer	0.00216	0.00216	CbGpPWpGaD
Trabectedin—SRC—Cell surface interactions at the vascular wall—NRAS—bile duct cancer	0.00216	0.00216	CbGpPWpGaD
Trabectedin—SRC—Rac1/Pak1/p38/MMP-2 pathway—HRAS—bile duct cancer	0.00216	0.00216	CbGpPWpGaD
Trabectedin—SRC—Androgen receptor signaling pathway—EGFR—bile duct cancer	0.00214	0.00214	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—ERBB2—bile duct cancer	0.00214	0.00214	CbGpPWpGaD
Trabectedin—SRC—NCAM signaling for neurite out-growth—HRAS—bile duct cancer	0.00213	0.00213	CbGpPWpGaD
Trabectedin—SRC—CDC42 signaling events—HRAS—bile duct cancer	0.00209	0.00209	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—FAR2—bile duct cancer	0.00207	0.00207	CbGpPWpGaD
Trabectedin—SRC—ErbB1 downstream signaling—NRAS—bile duct cancer	0.00206	0.00206	CbGpPWpGaD
Trabectedin—SRC—NCAM signaling for neurite out-growth—IL6—bile duct cancer	0.00204	0.00204	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—NRAS—bile duct cancer	0.00203	0.00203	CbGpPWpGaD
Trabectedin—SRC—L1CAM interactions—EGFR—bile duct cancer	0.00202	0.00202	CbGpPWpGaD
Trabectedin—SRC—Leptin signaling pathway—HRAS—bile duct cancer	0.00197	0.00197	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—ERBB2—bile duct cancer	0.00192	0.00192	CbGpPWpGaD
Trabectedin—SRC—GAB1 signalosome—EGFR—bile duct cancer	0.00192	0.00192	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways in Glioblastoma—TP53—bile duct cancer	0.00192	0.00192	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—NRAS—bile duct cancer	0.00192	0.00192	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—TGFB1—bile duct cancer	0.00192	0.00192	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—ERBB2—bile duct cancer	0.00192	0.00192	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—ERBB2—bile duct cancer	0.00192	0.00192	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—ERBB2—bile duct cancer	0.00191	0.00191	CbGpPWpGaD
Trabectedin—SRC—ErbB1 downstream signaling—EGFR—bile duct cancer	0.00188	0.00188	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—bile duct cancer	0.00187	0.00187	CbGpPWpGaD
Trabectedin—SRC—Cell surface interactions at the vascular wall—KRAS—bile duct cancer	0.00186	0.00186	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways in Glioblastoma—HRAS—bile duct cancer	0.00184	0.00184	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—MMP9—bile duct cancer	0.00184	0.00184	CbGpPWpGaD
Trabectedin—SRC—PDGFR-beta signaling pathway—NRAS—bile duct cancer	0.00179	0.00179	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—ERBB2—bile duct cancer	0.00178	0.00178	CbGpPWpGaD
Trabectedin—SRC—ErbB1 downstream signaling—KRAS—bile duct cancer	0.00177	0.00177	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—ERBB2—bile duct cancer	0.00177	0.00177	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—ERBB2—bile duct cancer	0.00175	0.00175	CbGpPWpGaD
Trabectedin—PTGS1—Selenium Micronutrient Network—IL6—bile duct cancer	0.00175	0.00175	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—KRAS—bile duct cancer	0.00175	0.00175	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—ERBB2—bile duct cancer	0.00174	0.00174	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—ERBB2—bile duct cancer	0.00169	0.00169	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	0.00168	0.00168	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—KRAS—bile duct cancer	0.00165	0.00165	CbGpPWpGaD
Trabectedin—SRC—EPH-Ephrin signaling—HRAS—bile duct cancer	0.00165	0.00165	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	0.00164	0.00164	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—NRAS—bile duct cancer	0.00163	0.00163	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—FAR2—bile duct cancer	0.0016	0.0016	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—TGFB1—bile duct cancer	0.00159	0.00159	CbGpPWpGaD
Trabectedin—SRC—Cell surface interactions at the vascular wall—HRAS—bile duct cancer	0.00158	0.00158	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—ERBB2—bile duct cancer	0.00158	0.00158	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—TP53—bile duct cancer	0.00158	0.00158	CbGpPWpGaD
Trabectedin—SRC—Integrin-mediated Cell Adhesion—HRAS—bile duct cancer	0.00157	0.00157	CbGpPWpGaD
Trabectedin—SRC—PDGFR-beta signaling pathway—KRAS—bile duct cancer	0.00154	0.00154	CbGpPWpGaD
Trabectedin—SRC—Disease—RNF43—bile duct cancer	0.00154	0.00154	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.00151	0.00151	CbGpPWpGaD
Trabectedin—SRC—ErbB1 downstream signaling—HRAS—bile duct cancer	0.00151	0.00151	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—HRAS—bile duct cancer	0.00151	0.00151	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—MET—bile duct cancer	0.0015	0.0015	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—HRAS—bile duct cancer	0.00149	0.00149	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—EGFR—bile duct cancer	0.00148	0.00148	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—FAR2—bile duct cancer	0.00147	0.00147	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—NRAS—bile duct cancer	0.00146	0.00146	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—FAR2—bile duct cancer	0.00146	0.00146	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—NRAS—bile duct cancer	0.00146	0.00146	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—NRAS—bile duct cancer	0.00145	0.00145	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—IL6—bile duct cancer	0.00144	0.00144	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—IL6—bile duct cancer	0.00142	0.00142	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—SMAD4—bile duct cancer	0.0014	0.0014	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—HRAS—bile duct cancer	0.0014	0.0014	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—GNAS—bile duct cancer	0.0014	0.0014	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—KRAS—bile duct cancer	0.0014	0.0014	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.00138	0.00138	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—NRAS—bile duct cancer	0.00136	0.00136	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—IDH2—bile duct cancer	0.00136	0.00136	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—NRAS—bile duct cancer	0.00135	0.00135	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—IL6—bile duct cancer	0.00134	0.00134	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—HGF—bile duct cancer	0.00134	0.00134	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—EGFR—bile duct cancer	0.00133	0.00133	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—NRAS—bile duct cancer	0.00133	0.00133	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—EGFR—bile duct cancer	0.00133	0.00133	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—EGFR—bile duct cancer	0.00133	0.00133	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—NRAS—bile duct cancer	0.00133	0.00133	CbGpPWpGaD
Trabectedin—SRC—Disease—IDH1—bile duct cancer	0.00132	0.00132	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—EGFR—bile duct cancer	0.00132	0.00132	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—TP53—bile duct cancer	0.00131	0.00131	CbGpPWpGaD
Trabectedin—SRC—PDGFR-beta signaling pathway—HRAS—bile duct cancer	0.00131	0.00131	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—KRAS—bile duct cancer	0.00126	0.00126	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—MMP2—bile duct cancer	0.00126	0.00126	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—KRAS—bile duct cancer	0.00125	0.00125	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—KRAS—bile duct cancer	0.00125	0.00125	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—KRAS—bile duct cancer	0.00125	0.00125	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—EGFR—bile duct cancer	0.00124	0.00124	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—EGFR—bile duct cancer	0.00123	0.00123	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—ERBB2—bile duct cancer	0.00122	0.00122	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—EGFR—bile duct cancer	0.00121	0.00121	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—EGFR—bile duct cancer	0.00121	0.00121	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—NRAS—bile duct cancer	0.0012	0.0012	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—HRAS—bile duct cancer	0.00119	0.00119	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	0.00119	0.00119	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—HRAS—bile duct cancer	0.00117	0.00117	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—EGFR—bile duct cancer	0.00117	0.00117	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—KRAS—bile duct cancer	0.00117	0.00117	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—IDH1—bile duct cancer	0.00117	0.00117	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	0.00116	0.00116	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—KRAS—bile duct cancer	0.00116	0.00116	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—KRAS—bile duct cancer	0.00115	0.00115	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—KRAS—bile duct cancer	0.00114	0.00114	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—IL6—bile duct cancer	0.00114	0.00114	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—ERBB2—bile duct cancer	0.0011	0.0011	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	0.0011	0.0011	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—EGFR—bile duct cancer	0.0011	0.0011	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—RNF43—bile duct cancer	0.00108	0.00108	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—MET—bile duct cancer	0.00107	0.00107	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—HRAS—bile duct cancer	0.00107	0.00107	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—HRAS—bile duct cancer	0.00107	0.00107	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—HRAS—bile duct cancer	0.00107	0.00107	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—HRAS—bile duct cancer	0.00106	0.00106	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	0.00106	0.00106	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—KRAS—bile duct cancer	0.00103	0.00103	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—IL6—bile duct cancer	0.00103	0.00103	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—NOS2—bile duct cancer	0.00102	0.00102	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—IL6—bile duct cancer	0.00102	0.00102	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—IL6—bile duct cancer	0.00102	0.00102	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—IDH2—bile duct cancer	0.00101	0.00101	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—HRAS—bile duct cancer	0.000993	0.000993	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—HRAS—bile duct cancer	0.000984	0.000984	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	0.000977	0.000977	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—HRAS—bile duct cancer	0.000975	0.000975	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—HRAS—bile duct cancer	0.000971	0.000971	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—FAR2—bile duct cancer	0.000962	0.000962	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—IL6—bile duct cancer	0.00095	0.00095	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—MMP9—bile duct cancer	0.000943	0.000943	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—IL6—bile duct cancer	0.000942	0.000942	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—HRAS—bile duct cancer	0.000938	0.000938	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—IL6—bile duct cancer	0.000934	0.000934	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—IL6—bile duct cancer	0.000929	0.000929	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—NRAS—bile duct cancer	0.000925	0.000925	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—MMP2—bile duct cancer	0.000896	0.000896	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—HRAS—bile duct cancer	0.000879	0.000879	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—IDH1—bile duct cancer	0.000871	0.000871	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—EGFR—bile duct cancer	0.000842	0.000842	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—IL6—bile duct cancer	0.000842	0.000842	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—NRAS—bile duct cancer	0.000837	0.000837	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—KRAS—bile duct cancer	0.000796	0.000796	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—ERBB2—bile duct cancer	0.000785	0.000785	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—IDH2—bile duct cancer	0.000782	0.000782	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—SLC5A5—bile duct cancer	0.000769	0.000769	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—EGFR—bile duct cancer	0.000762	0.000762	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000721	0.000721	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—KRAS—bile duct cancer	0.00072	0.00072	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—IDH2—bile duct cancer	0.000719	0.000719	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—IDH2—bile duct cancer	0.000713	0.000713	CbGpPWpGaD
Trabectedin—SRC—Disease—TGFBR2—bile duct cancer	0.000704	0.000704	CbGpPWpGaD
Trabectedin—SRC—Immune System—HGF—bile duct cancer	0.0007	0.0007	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—ERBB2—bile duct cancer	0.000693	0.000693	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—HRAS—bile duct cancer	0.000676	0.000676	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—MMP9—bile duct cancer	0.000673	0.000673	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—IDH1—bile duct cancer	0.000672	0.000672	CbGpPWpGaD
Trabectedin—SRC—Disease—SMAD4—bile duct cancer	0.000666	0.000666	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—ERBB2—bile duct cancer	0.000666	0.000666	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—IL6—bile duct cancer	0.000647	0.000647	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—IDH1—bile duct cancer	0.000618	0.000618	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—IDH1—bile duct cancer	0.000613	0.000613	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—HRAS—bile duct cancer	0.000612	0.000612	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—GNAS—bile duct cancer	0.000598	0.000598	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—NRAS—bile duct cancer	0.000597	0.000597	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—IL6—bile duct cancer	0.000586	0.000586	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—NRAS—bile duct cancer	0.000586	0.000586	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—SLC5A5—bile duct cancer	0.000575	0.000575	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—TGFB1—bile duct cancer	0.000555	0.000555	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TGFB1—bile duct cancer	0.000544	0.000544	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—EGFR—bile duct cancer	0.000544	0.000544	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—NRAS—bile duct cancer	0.000527	0.000527	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—KRAS—bile duct cancer	0.000514	0.000514	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—NRAS—bile duct cancer	0.000506	0.000506	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—KRAS—bile duct cancer	0.000504	0.000504	CbGpPWpGaD
Trabectedin—SRC—Disease—NOS2—bile duct cancer	0.000496	0.000496	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TGFBR2—bile duct cancer	0.000493	0.000493	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—EGFR—bile duct cancer	0.00048	0.00048	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—GNAS—bile duct cancer	0.000475	0.000475	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—IDH2—bile duct cancer	0.00047	0.00047	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—SMAD4—bile duct cancer	0.000466	0.000466	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—EGFR—bile duct cancer	0.000461	0.000461	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—KRAS—bile duct cancer	0.000454	0.000454	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TP53—bile duct cancer	0.000448	0.000448	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GNAS—bile duct cancer	0.000447	0.000447	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—SLC5A5—bile duct cancer	0.000443	0.000443	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—HRAS—bile duct cancer	0.000437	0.000437	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—KRAS—bile duct cancer	0.000436	0.000436	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—HRAS—bile duct cancer	0.000429	0.000429	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—IL6—bile duct cancer	0.000418	0.000418	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000415	0.000415	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—SLC5A5—bile duct cancer	0.000408	0.000408	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—SLC5A5—bile duct cancer	0.000404	0.000404	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—IDH1—bile duct cancer	0.000404	0.000404	CbGpPWpGaD
Trabectedin—SRC—Immune System—ERBB2—bile duct cancer	0.000404	0.000404	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—HRAS—bile duct cancer	0.000386	0.000386	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000379	0.000379	CbGpPWpGaD
Trabectedin—SRC—Disease—ERBB2—bile duct cancer	0.000373	0.000373	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—HRAS—bile duct cancer	0.00037	0.00037	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—IL6—bile duct cancer	0.000369	0.000369	CbGpPWpGaD
Trabectedin—SRC—Disease—PTGS2—bile duct cancer	0.000364	0.000364	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GNAS—bile duct cancer	0.000345	0.000345	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PTGS2—bile duct cancer	0.000321	0.000321	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GNAS—bile duct cancer	0.000317	0.000317	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GNAS—bile duct cancer	0.000314	0.000314	CbGpPWpGaD
Trabectedin—SRC—Immune System—NRAS—bile duct cancer	0.000307	0.000307	CbGpPWpGaD
Trabectedin—SRC—Disease—NRAS—bile duct cancer	0.000284	0.000284	CbGpPWpGaD
Trabectedin—SRC—Immune System—EGFR—bile duct cancer	0.00028	0.00028	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SLC5A5—bile duct cancer	0.000267	0.000267	CbGpPWpGaD
Trabectedin—SRC—Immune System—KRAS—bile duct cancer	0.000264	0.000264	CbGpPWpGaD
Trabectedin—SRC—Disease—TGFB1—bile duct cancer	0.000264	0.000264	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ERBB2—bile duct cancer	0.000261	0.000261	CbGpPWpGaD
Trabectedin—SRC—Disease—EGFR—bile duct cancer	0.000258	0.000258	CbGpPWpGaD
Trabectedin—SRC—Disease—KRAS—bile duct cancer	0.000244	0.000244	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PTGS2—bile duct cancer	0.00024	0.00024	CbGpPWpGaD
Trabectedin—SRC—Immune System—HRAS—bile duct cancer	0.000225	0.000225	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MMP9—bile duct cancer	0.000224	0.000224	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL6—bile duct cancer	0.000215	0.000215	CbGpPWpGaD
Trabectedin—SRC—Disease—HRAS—bile duct cancer	0.000207	0.000207	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GNAS—bile duct cancer	0.000207	0.000207	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NRAS—bile duct cancer	0.000199	0.000199	CbGpPWpGaD
Trabectedin—SRC—Disease—IL6—bile duct cancer	0.000199	0.000199	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PTGS2—bile duct cancer	0.000185	0.000185	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TGFB1—bile duct cancer	0.000185	0.000185	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EGFR—bile duct cancer	0.000181	0.000181	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—KRAS—bile duct cancer	0.000171	0.000171	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PTGS2—bile duct cancer	0.00017	0.00017	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PTGS2—bile duct cancer	0.000169	0.000169	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TP53—bile duct cancer	0.000152	0.000152	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HRAS—bile duct cancer	0.000145	0.000145	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IL6—bile duct cancer	0.000139	0.000139	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PTGS2—bile duct cancer	0.000111	0.000111	CbGpPWpGaD
